HU170643B - - Google Patents

Info

Publication number
HU170643B
HU170643B HUSC510A HUSC000510A HU170643B HU 170643 B HU170643 B HU 170643B HU SC510 A HUSC510 A HU SC510A HU SC000510 A HUSC000510 A HU SC000510A HU 170643 B HU170643 B HU 170643B
Authority
HU
Hungary
Application number
HUSC510A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU170643B publication Critical patent/HU170643B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002Carbocyclic rings fused
    • C07J53/0043 membered carbocyclic rings
    • C07J53/0053 membered carbocyclic rings in position 12
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
HUSC510A 1974-03-01 1975-02-28 HU170643B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2410443A DE2410443A1 (de) 1974-03-01 1974-03-01 11beta-fluor-androstene

Publications (1)

Publication Number Publication Date
HU170643B true HU170643B (hu) 1977-07-28

Family

ID=5909131

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSC510A HU170643B (hu) 1974-03-01 1975-02-28

Country Status (16)

Country Link
US (1) US3966713A (hu)
JP (1) JPS50121259A (hu)
BE (1) BE826139A (hu)
CA (1) CA1037024A (hu)
CS (1) CS181779B2 (hu)
DD (1) DD118623A5 (hu)
DE (1) DE2410443A1 (hu)
DK (1) DK137539C (hu)
ES (1) ES435204A1 (hu)
FR (1) FR2262528B1 (hu)
GB (1) GB1504410A (hu)
HU (1) HU170643B (hu)
IL (1) IL46712A0 (hu)
NL (1) NL7502445A (hu)
SE (1) SE7502239L (hu)
SU (1) SU656529A3 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
PT1175433E (pt) 1999-05-04 2005-11-30 Strakan Int Ltd Glicosidos androgenos e sua actividade androgenica
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
US7960368B2 (en) * 2008-03-05 2011-06-14 Everstra, Inc. Bismethylene-17A carbolactones and related uses
EP2367808A4 (en) * 2008-11-25 2012-05-09 Evestra Inc g-LACTONES OF 3- (6,6-ETHYLENE-17β-HYDROXY-3-OXO-17α-PREGEN-4-EENE-17α-YL) PROGESTATIVE PROPIONIC ACID

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056807A (en) * 1961-10-09 1962-10-02 Upjohn Co Process for the preparation of fluorosteroids
US3875148A (en) * 1971-07-09 1975-04-01 Glaxo Lab Ltd 9{60 -unsubstituted-11{62 -bromo-19-norsteroids
US3767685A (en) * 1972-02-02 1973-10-23 Akzona Inc Novel 11beta-halo-steroids of the oestrane series

Also Published As

Publication number Publication date
JPS50121259A (hu) 1975-09-23
GB1504410A (en) 1978-03-22
NL7502445A (nl) 1975-09-03
AU7855175A (en) 1976-08-26
SU656529A3 (ru) 1979-04-05
CS181779B2 (en) 1978-03-31
CA1037024A (en) 1978-08-22
SE7502239L (hu) 1975-09-02
DK137539B (da) 1978-03-20
DE2410443A1 (de) 1975-09-11
FR2262528A1 (hu) 1975-09-26
DK78775A (hu) 1975-11-03
IL46712A0 (en) 1975-04-25
ES435204A1 (es) 1976-12-16
FR2262528B1 (hu) 1978-06-30
DK137539C (da) 1978-09-04
BE826139A (fr) 1975-08-28
DD118623A5 (hu) 1976-03-12
US3966713A (en) 1976-06-29

Similar Documents

Publication Publication Date Title
DK141995C (hu)
JPS50139247A (hu)
DK78275A (hu)
FR2262528B1 (hu)
JPS5030108A (hu)
FR2277803B1 (hu)
JPS50124901A (hu)
JPS5122462U (hu)
JPS50124319U (hu)
JPS50150945U (hu)
JPS50149857U (hu)
JPS50145173U (hu)
JPS50141608U (hu)
JPS50129087U (hu)
CH575064A5 (hu)
CH576579A5 (hu)
CH572117A5 (hu)
CH583017A5 (hu)
CH566759A5 (hu)
CH352875A4 (hu)
CH1637174A4 (hu)
BG27089A3 (hu)
CH573303A5 (hu)
CH573721A5 (hu)
BG22011A1 (hu)